Literature DB >> 23486979

Fatty liver accompanies an increase in lactobacillus species in the hind gut of C57BL/6 mice fed a high-fat diet.

Huawei Zeng1, Jun Liu, Matthew I Jackson, Feng-Qi Zhao, Lin Yan, Gerald F Combs.   

Abstract

High-fat (HF) diets can produce obesity and have been linked to the development of nonalcoholic fatty liver disease and changes in the gut microbiome. To test the hypothesis that HF feeding increases certain predominant hind gut bacteria and development of steatohepatitis, C57BL/6 mice were fed an HF (45% energy) or low-fat (LF) (10% energy) diet for 10 wk. At the end of the feeding period, body weights in the HF group were 34% greater than those in the LF group (P < 0.05). These changes were associated with dramatic increases in lipid droplet number and size, inflammatory cell infiltration, and inducible nitric oxide (NO) synthase protein concentration in the livers of mice fed the HF diet. Consistent with the fatty liver phenotype, plasma leptin and tumor necrosis factor-α concentrations were also elevated in mice fed the HF diet, indicative of chronic inflammation. Eight of 12 pairs of polymerase chain reaction (PCR) primers for bacterial species that typically predominate hind gut microbial ecology generated specific PCR products from the fecal DNA samples. The amount of DNA from Lactobacillus gasseri and/or Lactobacillus taiwanensis in the HF group was 6900-fold greater than that in the LF group. Many of these bacteria are bile acid resistant and are capable of bile acid deconjugation. Because bile acids are regulators of hepatic lipid metabolism, the marked increase of gut L. gasseri and/or L. taiwanensis species bacteria with HF feeding may play a role in development of steatohepatitis in this model.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23486979      PMCID: PMC3738235          DOI: 10.3945/jn.112.172460

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  39 in total

Review 1.  An overview of real-time quantitative PCR: applications to quantify cytokine gene expression.

Authors:  A Giulietti; L Overbergh; D Valckx; B Decallonne; R Bouillon; C Mathieu
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Inducible nitric oxide distribution in the fatty liver of a mouse with high fat diet-induced obesity.

Authors:  Seung-Kwon Ha; Chanhee Chae
Journal:  Exp Anim       Date:  2010

3.  Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice.

Authors:  Marc-Emmanuel Dumas; Richard H Barton; Ayo Toye; Olivier Cloarec; Christine Blancher; Alice Rothwell; Jane Fearnside; Roger Tatoud; Véronique Blanc; John C Lindon; Steve C Mitchell; Elaine Holmes; Mark I McCarthy; James Scott; Dominique Gauguier; Jeremy K Nicholson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-08       Impact factor: 11.205

Review 4.  The search for human obesity genes.

Authors:  A G Comuzzie; D B Allison
Journal:  Science       Date:  1998-05-29       Impact factor: 47.728

Review 5.  AMP-activated protein kinase signaling in metabolic regulation.

Authors:  Yun Chau Long; Juleen R Zierath
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

6.  The gut microbiota as an environmental factor that regulates fat storage.

Authors:  Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

Review 7.  Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status.

Authors:  D Grahame Hardie
Journal:  Endocrinology       Date:  2003-09-04       Impact factor: 4.736

8.  High-fat diet decreases cancellous bone mass but has no effect on cortical bone mass in the tibia in mice.

Authors:  Jay J Cao; Brian R Gregoire; Hongwei Gao
Journal:  Bone       Date:  2009-03-03       Impact factor: 4.398

Review 9.  Leptin in the regulation of immunity, inflammation, and hematopoiesis.

Authors:  G Fantuzzi; R Faggioni
Journal:  J Leukoc Biol       Date:  2000-10       Impact factor: 4.962

10.  Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii.

Authors:  M Million; M Maraninchi; M Henry; F Armougom; H Richet; P Carrieri; R Valero; D Raccah; B Vialettes; D Raoult
Journal:  Int J Obes (Lond)       Date:  2011-08-09       Impact factor: 5.095

View more
  23 in total

Review 1.  The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Monica D Chow; Yi-Horng Lee; Grace L Guo
Journal:  Mol Aspects Med       Date:  2017-05-05

Review 2.  Gut microbiome and liver disease.

Authors:  Naga S Betrapally; Patrick M Gillevet; Jasmohan S Bajaj
Journal:  Transl Res       Date:  2016-07-15       Impact factor: 7.012

Review 3.  Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet.

Authors:  Zeinab Mokhtari; Deanna L Gibson; Azita Hekmatdoost
Journal:  Adv Nutr       Date:  2017-03-15       Impact factor: 8.701

Review 4.  Nonalcoholic fatty liver disease and the gut microbiome: Are bacteria responsible for fatty liver?

Authors:  Tien S Dong; Jonathan P Jacobs
Journal:  Exp Biol Med (Maywood)       Date:  2019-03-14

5.  Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.

Authors:  Changtao Jiang; Cen Xie; Fei Li; Limin Zhang; Robert G Nichols; Kristopher W Krausz; Jingwei Cai; Yunpeng Qi; Zhong-Ze Fang; Shogo Takahashi; Naoki Tanaka; Dhimant Desai; Shantu G Amin; Istvan Albert; Andrew D Patterson; Frank J Gonzalez
Journal:  J Clin Invest       Date:  2014-12-15       Impact factor: 14.808

Review 6.  Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota.

Authors:  Sena Bluemel; Brandon Williams; Rob Knight; Bernd Schnabl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-09-29       Impact factor: 4.052

7.  Dietary copper-fructose interactions alter gut microbial activity in male rats.

Authors:  Ming Song; Xiaohong Li; Xiang Zhang; Hongxue Shi; Miriam B Vos; Xiaoli Wei; Yuhua Wang; Hong Gao; Eric C Rouchka; Xinmin Yin; Zhanxiang Zhou; Russell A Prough; Matthew C Cave; Craig J McClain
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-10-12       Impact factor: 4.052

Review 8.  Nonalcoholic fatty liver disease and colorectal cancer: Correlation and missing links.

Authors:  Debrup Chakraborty; Jing Wang
Journal:  Life Sci       Date:  2020-10-02       Impact factor: 5.037

Review 9.  The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD).

Authors:  Zahra Safari; Philippe Gérard
Journal:  Cell Mol Life Sci       Date:  2019-01-25       Impact factor: 9.207

10.  Attenuating Effects of Dieckol on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Decreasing the NLRP3 Inflammasome and Pyroptosis.

Authors:  Seyeon Oh; Myeongjoo Son; Kyung-A Byun; Ji Tae Jang; Chang Hu Choi; Kuk Hui Son; Kyunghee Byun
Journal:  Mar Drugs       Date:  2021-05-30       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.